Pharmigene to distribute VarSome Clinical in Taiwan

By Tomas Kucera on March, 30 2020

Stay up to date

Back to main Blog
Tomas Kucera

Head of Strategic Alliances & Channel Partners

Pharmigene Taiwan

Lausanne, Switzerland - March 26, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Pharmigene, a leading distributor providing innovative solutions such as 10x Genomics, Swift Biosciences, GenDx etc. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Pharmigene’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

Jin-Jer Chen, Chairman of Pharmigene, said:This new partnership helps us to deliver high-quality, state-of-the-art bioinformatics services in the clinical and research fields, along with our wide portfolio of assays for diagnostic tests, HLA typing, reproductive healthcare, library preparation kits.
Tomas Kucera, Head of Business Development of Saphetor SA, commented:We are excited to count Shiva Scientific among our regional distributors for our bioinformatics tools, and we are prepared to work closely with their team to provide their clients with an integrated solution for diagnostics purposes.’

About Pharmigene

Pharmigene is established in 2005 and funded by venture capital firms and individuals. Our goal is to innovate and commercialize diagnostic tests that enable individuals to be better informed about their genomic makeup and to make decisions that better their health. We have licensed exclusive world-wide rights and transferred key know-how from Academia Sinica relating to the genetic markers that are associated with adverse drug reactions caused by several popular drugs. We have obtained ISO 13485 / 9001 and GMP certifications, and are manufacturing our DNA genetic tests under the most stringent guideline. In developing our DNA genetic tests, we also have validated our tests with clinical studies that involved hundreds and thousands of patients. Today our DNA genetic tests are available worldwide. Specifically several of our tests have obtained IVD clearance from Department of Health in Taiwan.Since 2017, Pharmigene has started to represent genomics related products, such as illumina, 10x genomics, Swift Biosciences and Lexogen. The purpose is to provide complete solutions to researchers and further develop products for clinical diagnosis.

About Saphetor SA

Saphetor SA, is a Swiss precision-medicine company dedicated to large-scale identification and interpretation of human genetic variants by leveraging proprietary algorithms and expert domain knowledge. Saphetor is the creator of VarSome, a suite of intuitive and data-driven bioinformatics solutions both for clinicians and researchers. search engine and professional community is freely accessible, featuring a widely-recognized community-driven knowledge base that enables flexible queries across more than 50 genetic and genomic data resources. VarSome Clinical is a clinically-accredited platform allowing fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels, which helps clinicians reach faster and more accurate diagnoses and treatment decisions for genetic conditions.

Contact Pharmigene as VarSome distributor in Taiwan

Presenting VarSome Clinical

Learn about VarSome Clinical

Submit a Comment

Stay up to date